Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Azenta Inc (AZTA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: AZTA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -15.66% | Avg. Invested days 41 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.56B USD | Price to earnings Ratio - | 1Y Target Price 53.25 |
Price to earnings Ratio - | 1Y Target Price 53.25 | ||
Volume (30-day avg) 693241 | Beta 1.52 | 52 Weeks Range 33.33 - 63.58 | Updated Date 04/2/2025 |
52 Weeks Range 33.33 - 63.58 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.17 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -24.44% | Operating Margin (TTM) -7.4% |
Management Effectiveness
Return on Assets (TTM) -1.65% | Return on Equity (TTM) -8% |
Valuation
Trailing PE - | Forward PE 28.9 | Enterprise Value 1150029564 | Price to Sales(TTM) 2.35 |
Enterprise Value 1150029564 | Price to Sales(TTM) 2.35 | ||
Enterprise Value to Revenue 1.74 | Enterprise Value to EBITDA 61.76 | Shares Outstanding 45695600 | Shares Floating 40052186 |
Shares Outstanding 45695600 | Shares Floating 40052186 | ||
Percent Insiders 1.66 | Percent Institutions 115.97 |
Analyst Ratings
Rating 3.43 | Target Price 59 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold 5 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Azenta Inc
Company Overview
History and Background
Azenta, Inc., formerly Brooks Automation, was founded in 1978. Initially focused on automation solutions for the semiconductor industry, it evolved to serve life sciences, with a name change reflecting that shift.
Core Business Areas
- Life Sciences: Provides sample management and automation solutions for pharmaceutical, biotech, and academic research. This includes automated storage systems, consumables, and genomic services.
- Semiconductor Solutions: Offers automation and cryogenic systems for the semiconductor and related industries, including robotics, vacuum technology, and contamination control.
Leadership and Structure
Azenta Inc. is led by CEO Steve Schwartz. The organizational structure is divided into two main business segments: Life Sciences and Semiconductor Solutions, each with its own operational and commercial teams.
Top Products and Market Share
Key Offerings
- Automated Storage Systems: These systems provide secure and efficient storage for biological samples. While specific market share data is difficult to pinpoint due to the fragmented nature of the sample management market, Azenta is considered a leader in this space. Competitors include BioStorage Technologies (Thermo Fisher Scientific), Hamilton Storage Technologies, and TTP Labtech.
- Genomic Services: Azenta offers a range of genomic services, including sequencing and library preparation. The genomics services market is highly competitive with dominant players like Illumina (ILMN) and Thermo Fisher Scientific (TMO) holding the majority of market share. Azenta is a smaller player focusing on specific niches within the overall genomic services market.
- Cryogenic Systems: Supplies cryogenic systems essential for research and storage of materials at ultra-low temperatures. While market share isn't precisely defined, Azenta operates in the broader cryogenic equipment market alongside companies like Chart Industries (GTLS) and MVE Biological Solutions.
- Robotics Automation: supplies robotics for the movement and organization of samples to allow the researcher to spend more time developing new techniques. Market is fragmented but larger competitors are Hudson Robotics and Peak Analysis.
Market Dynamics
Industry Overview
The life sciences industry is experiencing growth driven by increasing investment in research and development, personalized medicine, and drug discovery. The semiconductor industry is cyclical but generally growing due to increasing demand for electronics and computing power.
Positioning
Azenta is positioned as a provider of integrated solutions for both life sciences and semiconductor industries. Its competitive advantages lie in its expertise in automation, sample management, and its global reach.
Total Addressable Market (TAM)
The total addressable market for sample management solutions and semiconductor automation is estimated to be in the billions of dollars annually. Azenta is positioned to capture a share of this market through its diverse product and service offerings and strategic acquisitions.
Upturn SWOT Analysis
Strengths
- Diversified revenue streams (Life Sciences and Semiconductor)
- Strong technological expertise in automation and sample management
- Global presence and distribution network
- Established relationships with key customers
- Recurring revenue from consumables and services
Weaknesses
- Reliance on cyclical semiconductor industry
- Competition from larger players with broader product portfolios
- Potential for disruption from new technologies
- Integration challenges from acquisitions
- Susceptible to changes in global economic conditions
Opportunities
- Expanding into new geographic markets
- Developing innovative solutions for emerging applications
- Acquiring complementary technologies and businesses
- Partnering with leading research institutions
- Capitalizing on the growing demand for personalized medicine
Threats
- Economic downturns affecting R&D spending
- Increased competition from existing and new players
- Technological obsolescence
- Regulatory changes impacting the life sciences industry
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- TMO
- ILMN
- WAT
Competitive Landscape
Azenta faces competition from larger, more diversified players like Thermo Fisher Scientific and Illumina. Azenta's advantages lie in its specialized expertise and focus on specific niche markets. Azenta needs to scale to stay relevant.
Major Acquisitions
B Medical Systems
- Year: 2022
- Acquisition Price (USD millions): 475
- Strategic Rationale: Expanded Azenta's cold chain capabilities for sample management.
Growth Trajectory and Initiatives
Historical Growth: Historical growth can be assessed by reviewing past revenue and earnings performance over the past few years.
Future Projections: Analyst estimates would provide projections for future revenue and earnings growth.
Recent Initiatives: Recent strategic initiatives include acquisitions aimed at expanding its product portfolio and market reach, as well as investments in research and development.
Summary
Azenta's strengths lie in its diversification and technological expertise within the life sciences and semiconductor sectors. However, its reliance on the cyclical semiconductor industry and competition from larger players pose challenges. Strategic acquisitions and geographic expansion are crucial for future growth, but Azenta must also maintain a strong focus on innovation to stay ahead.
Similar Companies
ILMN
Illumina Inc
ILMN
Illumina Inc
MKTX
MarketAxess Holdings Inc
MKTX
MarketAxess Holdings Inc
TMO
Thermo Fisher Scientific Inc
TMO
Thermo Fisher Scientific Inc
WAT
Waters Corporation
WAT
Waters Corporation
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
- Press releases
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is based on estimates and may not be precise. Investment decisions should be made based on individual research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Azenta Inc
Exchange NASDAQ | Headquaters Burlington, MA, United States | ||
IPO Launch date 1995-02-02 | President, CEO & Director Mr. John P. Marotta | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 3000 | Website https://www.azenta.com |
Full time employees 3000 | Website https://www.azenta.com | ||
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.